STAT News · Scour

Amid federal pressure, more hospitals stop gender-affirming care for minors

statnews.com·14w

Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s

statnews.com·14w

STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill

statnews.com·14w

STAT+: A rival goes after Ocular Therapeutix on eve of pivotal readout on eye treatment

statnews.com·14w

What to know about TrumpRx, the Trump administration’s prescription drug platform

statnews.com·14w

STAT+: Novo and Lilly both see price cuts as helpful for long-term gain

statnews.com·14w

STAT+: Pharmalittle: We’re reading about Super Bowl drug ads, an FTC deal with Express Scripts, and more

statnews.com·14w

Let’s revisit the subject of raw milk

statnews.com·14w

Dispute between Corcept Therapeutics, FDA runs deep

statnews.com·14w

STAT+: Nektar Therapeutics is trying to stage a comeback. But a big test awaits

statnews.com·14w

Opinion: TrumpRx has a fundamental flaw

statnews.com·14w

STAT+: Inside HHS’ anti-fraud efforts: An aggressive crackdown sweeps up mainly Democratic-led states

statnews.com·14w

STAT+: Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock

statnews.com·14w·Hacker News

Opinion: We helped create Medicare Advantage. Here’s how to fix it

statnews.com·14w

A sneak peek of pharma’s Super Bowl ads: GLP-1s, tight ends, and more

statnews.com·14w

New PBM law could open door to direct sales between employers, drugmakers

statnews.com·14w

Study ties particle pollution from wildfire smoke to 24,100 U.S. deaths per year

statnews.com·14w

STAT+: Epic launches AI Charting, potentially scrambling the ambient scribe market

statnews.com·14w

STAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access

statnews.com·14w

STAT+: The FDA questions underlying Utah’s AI prescription pilot

statnews.com·14w

Log in to enable infinite scrolling